Klaructam® is a combination of Cefotaxime and Sulbactam for empiric treatment of community-acquired and nosocomial infections outside the ICU caused by ESBL-producers and Acinetobacter spp.
Maxictam®-AF is a unique combination of Cefepime and Sulbactam for empiric treatment of nosocomial infections caused by multidrug-resistant pathogens.
Bianem-AF (biapenem) is a drug for the empiric treatment of severe nosocomial and community-acquired infections caused by multi-resistant strains of bacteria (such as ESBL producers and Pseudomonas aeruginosa).
Colistimet AF – International Non-Proprietary or Generic Name: Colistimethate sodium. Dosage form: powder for solution for injection, infusion and inhalation.